Results 141 to 150 of about 172,168 (267)

Chronic Myeloid Leukemia with Rare e1a3 BCR-ABL Transcript

open access: yesPakistan Journal of Medicine and Dentistry
Chronic myelogenous leukemia (CML) results from neoplastic transformation of a hematopoietic stem cell. It is cytogenetically characterized by the presence of Philadelphia chromosome which results from reciprocal translocation t(9;22) that juxtaposes ...
Najia Tabassum   +3 more
doaj  

Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated

open access: yesHaematologica, 2004
BACKGROUND AND OBJECTIVES: Cytotoxic T-lymphocytes (CTL) have been generated in vitro against chronic myeloid leukemia (CML)-associated BCR/ABL-specific peptides.
EF Posthuma   +9 more
doaj  

Immunogenicity of BCR-ABL-regulated tumorantigens

open access: yes, 2009
Im Hinblick auf die Entwicklung alternativer, immuntherapeutischer Ansätze zur Behandlung der Ph-positiven chronisch myeloischen Leukämie (CML) wurde in der vorliegenden Arbeit die Immunogenität des BCR-ABL-Fusionsproteins selbst, und der durch die BCR ...
Scheich, Florian
core  

Specific inhibition of bcr-abl gene expression by small interfering RNA

open access: yes, 2002
Small interfering RNAs (siRNAs) were designed to target the bcr-abl oncogene, which causes chronic myeloid leukemia (CML) and bcr-abl-positive acute lymphoblastic leukemia (ALL).
Ganser A   +5 more
core   +2 more sources

Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects

open access: yesHaematologica, 2005
BACKGROUND AND OBJECTIVES: The fusion oncoprotein bcr-abl that characterizes chronic myeloid leukemia (CML) is a leukemia-specific antigen, which may be immunogenic in vivo.
NM Butt   +5 more
doaj  

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.

open access: yesCancer Cell, 2009
T. O'Hare   +27 more
semanticscholar   +1 more source

e8a2 BCR–ABL: more frequent than other atypical BCR–ABL variants? [PDF]

open access: yesLeukemia, 2005
DEMEHRI S   +12 more
openaire   +2 more sources

The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia

open access: yes, 2014
Bei ca. 95% der chronisch myeloischen Leukämie (CML) und 20-30% der akuten lymphatischen Leukämie (ALL) des Erwachsenen liegt eine reziproke Chromosomentranslokation t(9;22)(q34;q11) vor, in deren Rahmen das BCR (Breakpoint Cluster Region) Gen auf ...
Rafiei, Anahita (Dr.)
core  

The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia

open access: yesHaematologica, 2006
BCR-ABL kinase mutations may confer resistance to imatinib in patients with chronic myeloid leukemia (CML), and may predict a poor outcome. We investigated whether rises in BCR-ABL transcript levels predicted mutation development in 82 CML patients ...
L Wang, K Knight, C Lucas, RE Clark
doaj  

Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation.

open access: yesACS Medicinal Chemistry Letters, 2017
K. Shimokawa   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy